2024 Q2 Form 10-Q Financial Statement

#000103835724000043 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $451.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $491.0M
Prepaid Expenses
Receivables $1.822B
Other Receivables
Total Short-Term Assets $3.030B
YoY Change -12.71%
LONG-TERM ASSETS
Property, Plant & Equipment $1.659B
YoY Change 1.16%
Goodwill $242.0M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $186.0M
YoY Change 8.77%
Total Long-Term Assets $34.48B
YoY Change 5.66%
TOTAL ASSETS
Total Short-Term Assets $3.030B
Total Long-Term Assets $34.48B
Total Assets $37.51B
YoY Change 3.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $11.00M
YoY Change -98.65%
Total Short-Term Liabilities $3.352B
YoY Change -14.82%
LONG-TERM LIABILITIES
Long-Term Debt $4.750B
YoY Change -6.75%
Other Long-Term Liabilities $916.0M
YoY Change 0.88%
Total Long-Term Liabilities $5.666B
YoY Change -5.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.352B
Total Long-Term Liabilities $5.666B
Total Liabilities $9.018B
YoY Change -9.25%
SHAREHOLDERS EQUITY
Retained Earnings $7.772B
YoY Change 38.96%
Common Stock $2.000M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.620B
YoY Change 7.16%
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $37.51B
YoY Change 3.89%

Cashflow Statement

Concept 2024 Q2 2024 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75038
CY2024Q1 dei City Area Code
CityAreaCode
972
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
444-9001
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
PXD
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
233675158 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
451000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240000000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1822000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1590000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
491000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
476000000 usd
CY2024Q1 pxd Investments In Affiliates
InvestmentsInAffiliates
134000000 usd
CY2023Q4 pxd Investments In Affiliates
InvestmentsInAffiliates
139000000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
132000000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3030000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2605000000 usd
CY2024Q1 us-gaap Proved Oil And Gas Property Successful Effort Method
ProvedOilAndGasPropertySuccessfulEffortMethod
44480000000 usd
CY2023Q4 us-gaap Proved Oil And Gas Property Successful Effort Method
ProvedOilAndGasPropertySuccessfulEffortMethod
43387000000 usd
CY2024Q1 us-gaap Unproved Oil And Gas Property Successful Effort Method
UnprovedOilAndGasPropertySuccessfulEffortMethod
5771000000 usd
CY2023Q4 us-gaap Unproved Oil And Gas Property Successful Effort Method
UnprovedOilAndGasPropertySuccessfulEffortMethod
5785000000 usd
CY2024Q1 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
18397000000 usd
CY2023Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
17639000000 usd
CY2024Q1 us-gaap Oil And Gas Property Successful Effort Method Net
OilAndGasPropertySuccessfulEffortMethodNet
31854000000 usd
CY2023Q4 us-gaap Oil And Gas Property Successful Effort Method Net
OilAndGasPropertySuccessfulEffortMethodNet
31533000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1659000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1656000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
543000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
186000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
179000000 usd
CY2024Q1 us-gaap Assets
Assets
37514000000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
35000000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
16000000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
48000000 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
230000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
40000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
11000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
28000000 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
113000000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
53000000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
259000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175000000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
170000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
181000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3352000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2974000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4750000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4807000000 usd
CY2024Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
113000000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
76000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4478000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4402000000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
315000000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
916000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
935000000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
245640802 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
245594927 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
2000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18436000000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18506000000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11983632 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11971806 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2620000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2617000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7772000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7280000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23590000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23171000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37514000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36613000000 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001038357
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
PIONEER NATURAL RESOURCES CO
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2702753
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
777 Hidden Ridge
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Irving
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
398000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
242000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
242000000 usd
CY2024Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2498000000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2414000000 usd
CY2024Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
55000000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesCurrent
CY2024Q1 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2023Q4 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesCurrent
CY2023Q4 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2023Q4 us-gaap Assets
Assets
36613000000 usd
CY2024Q1 pxd Interestand Other Income Loss
InterestandOtherIncomeLoss
28000000 usd
CY2023Q1 pxd Interestand Other Income Loss
InterestandOtherIncomeLoss
-37000000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-122000000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-44000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
25000000 usd
CY2024Q1 us-gaap Revenues
Revenues
4811000000 usd
CY2023Q1 us-gaap Revenues
Revenues
4541000000 usd
CY2024Q1 us-gaap Production Tax Expense
ProductionTaxExpense
206000000 usd
CY2023Q1 us-gaap Production Tax Expense
ProductionTaxExpense
208000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
774000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
664000000 usd
CY2024Q1 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
20000000 usd
CY2023Q1 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
15000000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84000000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5000000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
4000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
40000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
28000000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
24000000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
41000000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
3407000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
2984000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1404000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1557000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
335000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1095000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1222000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.68
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.19
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.57
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
234000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
235000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
239000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
244000000 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.56
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
5.58
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23171000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.56
CY2024Q1 us-gaap Dividends Cash
DividendsCash
603000000 usd
CY2024Q1 pxd Adjustments To Additional Paid In Capital Conversion Premium
AdjustmentsToAdditionalPaidInCapitalConversionPremium
-110000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
23000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-5000000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3000000 usd
CY2024Q1 pxd Stock Issued Or Vested During Period Value Stock Awards
StockIssuedOrVestedDuringPeriodValueStockAwards
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1095000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23590000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
22541000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
5.58
CY2023Q1 us-gaap Dividends Cash
DividendsCash
1314000000 usd
CY2023Q1 pxd Adjustments To Additional Paid In Capital Conversion Premium
AdjustmentsToAdditionalPaidInCapitalConversionPremium
-138000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
31000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-7000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
520000000 usd
CY2023Q1 pxd Stock Issued Or Vested During Period Value Stock Awards
StockIssuedOrVestedDuringPeriodValueStockAwards
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1222000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21838000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1095000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1222000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
774000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
664000000 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
6000000 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
0 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-71000000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-110000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
25000000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5000000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
4000000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2000000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000000 usd
CY2024Q1 pxd Noncash Gain Loss On Derivative Instruments
NoncashGainLossOnDerivativeInstruments
-98000000 usd
CY2023Q1 pxd Noncash Gain Loss On Derivative Instruments
NoncashGainLossOnDerivativeInstruments
-36000000 usd
CY2024Q1 pxd Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
22000000 usd
CY2023Q1 pxd Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
23000000 usd
CY2024Q1 pxd Investments In And Advances To Affiliates Valuation Adjustment
InvestmentsInAndAdvancesToAffiliatesValuationAdjustment
5000000 usd
CY2023Q1 pxd Investments In And Advances To Affiliates Valuation Adjustment
InvestmentsInAndAdvancesToAffiliatesValuationAdjustment
53000000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
29000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
51000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
231000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-461000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
148000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
63000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-34000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-380000000 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-32000000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-16000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
190000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
225000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
113000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1946000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2314000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4000000 usd
CY2024Q1 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
922000000 usd
CY2023Q1 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
1180000000 usd
CY2024Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
45000000 usd
CY2023Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
28000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-964000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1204000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
105000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
1449000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
292000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
580000000 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
23000000 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
31000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4000000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
520000000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
600000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
1319000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-771000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-950000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
211000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
160000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1032000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
451000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1192000000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates in the preparation of financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Preparation of the Company's consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from the estimates and assumptions utilized.</span></div>
CY2024Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
134000000 usd
CY2024Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
67000000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
201000000 usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
226000000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
139000000 usd
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
65000000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
205000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-5000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-53000000 usd
CY2024Q1 pxd Deferred Compensation Plan Asset Valuation Adjustment
DeferredCompensationPlanAssetValuationAdjustment
3000000 usd
CY2023Q1 pxd Deferred Compensation Plan Asset Valuation Adjustment
DeferredCompensationPlanAssetValuationAdjustment
-1000000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-122000000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-44000000 usd
CY2024Q1 pxd Debt Instrument Convertible Conversion Settlement Period After Notice
DebtInstrumentConvertibleConversionSettlementPeriodAfterNotice
25 d
CY2023Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
11000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
451000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240000000 usd
CY2023Q4 us-gaap Capitalized Exploratory Well Costs
CapitalizedExploratoryWellCosts
784000000 usd
CY2024Q1 us-gaap Capitalized Exploratory Well Cost Additions Pending Determination Of Proved Reserves
CapitalizedExploratoryWellCostAdditionsPendingDeterminationOfProvedReserves
775000000 usd
CY2024Q1 us-gaap Reclassification To Well Facilities And Equipment Based On Determination Of Proved Reserves
ReclassificationToWellFacilitiesAndEquipmentBasedOnDeterminationOfProvedReserves
728000000 usd
CY2024Q1 us-gaap Capitalized Exploratory Well Costs
CapitalizedExploratoryWellCosts
831000000 usd
CY2024Q1 us-gaap Capitalized Exploratory Well Costs That Have Been Capitalized For Period Of One Year Or Less
CapitalizedExploratoryWellCostsThatHaveBeenCapitalizedForPeriodOfOneYearOrLess
831000000 usd
CY2023Q4 us-gaap Capitalized Exploratory Well Costs That Have Been Capitalized For Period Of One Year Or Less
CapitalizedExploratoryWellCostsThatHaveBeenCapitalizedForPeriodOfOneYearOrLess
784000000 usd
CY2024Q1 us-gaap Capitalized Exploratory Well Costs That Have Been Capitalized For Period Greater Than One Year
CapitalizedExploratoryWellCostsThatHaveBeenCapitalizedForPeriodGreaterThanOneYear
0 usd
CY2023Q4 us-gaap Capitalized Exploratory Well Costs That Have Been Capitalized For Period Greater Than One Year
CapitalizedExploratoryWellCostsThatHaveBeenCapitalizedForPeriodGreaterThanOneYear
0 usd
CY2024Q1 us-gaap Capitalized Exploratory Well Costs
CapitalizedExploratoryWellCosts
831000000 usd
CY2023Q4 us-gaap Capitalized Exploratory Well Costs
CapitalizedExploratoryWellCosts
784000000 usd
CY2024Q1 us-gaap Projects That Have Exploratory Well Costs That Have Been Capitalized For Period Greater Than One Year
ProjectsThatHaveExploratoryWellCostsThatHaveBeenCapitalizedForPeriodGreaterThanOneYear
0 well
CY2023Q4 us-gaap Projects That Have Exploratory Well Costs That Have Been Capitalized For Period Greater Than One Year
ProjectsThatHaveExploratoryWellCostsThatHaveBeenCapitalizedForPeriodGreaterThanOneYear
0 well
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4789000000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4866000000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
28000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
31000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
4761000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
4835000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
11000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
28000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4750000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4807000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2000000000 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q1 pxd Option Indexed To Issuers Equity Cap Price
OptionIndexedToIssuersEquityCapPrice
129.92
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26000000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
5000000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4000000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
103000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
459000000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
2000000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
24000000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5000000 usd
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
442000000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
90000000 usd
CY2024Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
352000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4903000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4597000000 usd
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
1700000000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1500000000 usd
CY2024Q1 pxd Exxon Mobil Merger Related Costs
ExxonMobilMergerRelatedCosts
9000000 usd
CY2023Q1 pxd Exxon Mobil Merger Related Costs
ExxonMobilMergerRelatedCosts
0 usd
CY2024Q1 pxd Unoccupied Facility Expense
UnoccupiedFacilityExpense
8000000 usd
CY2023Q1 pxd Unoccupied Facility Expense
UnoccupiedFacilityExpense
9000000 usd
CY2024Q1 pxd Legal And Environmental Contingencies
LegalAndEnvironmentalContingencies
2000000 usd
CY2023Q1 pxd Legal And Environmental Contingencies
LegalAndEnvironmentalContingencies
16000000 usd
CY2024Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
11000000 usd
CY2024Q1 us-gaap Other General Expense
OtherGeneralExpense
5000000 usd
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
5000000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
24000000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
41000000 usd
CY2024Q1 pxd Right To Designate Director Ownership Percent
RightToDesignateDirectorOwnershipPercent
0.05
CY2024Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
0 usd
CY2023Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
42000000 usd
CY2024Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-238000000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-225000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-71000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-110000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
335000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1095000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1222000000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
2000000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
3000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1093000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1219000000 usd
CY2024Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2023Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
1000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
1093000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
1220000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
234000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
235000000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
5000000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
9000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
239000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
244000000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.68
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.19
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.57
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.00
CY2024Q1 pxd Common Stock Dividends Per Share Declared Base
CommonStockDividendsPerShareDeclaredBase
1.25
CY2024Q1 pxd Common Stock Dividends Per Share Declared Variable
CommonStockDividendsPerShareDeclaredVariable
1.31
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.56
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
603000000 usd
CY2023Q1 pxd Common Stock Dividends Per Share Declared Base
CommonStockDividendsPerShareDeclaredBase
1.10
CY2023Q1 pxd Common Stock Dividends Per Share Declared Variable
CommonStockDividendsPerShareDeclaredVariable
4.48
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
5.58
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1314000000 usd

Files In Submission

Name View Source Status
0001038357-24-000043-index-headers.html Edgar Link pending
0001038357-24-000043-index.html Edgar Link pending
0001038357-24-000043.txt Edgar Link pending
0001038357-24-000043-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pxd-20240331.htm Edgar Link pending
pxd-20240331.xsd Edgar Link pending
pxd-exx31120240331.htm Edgar Link pending
pxd-exx31220240331.htm Edgar Link pending
pxd-exx32120240331.htm Edgar Link pending
pxd-exx32220240331.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pxd-20240331_def.xml Edgar Link unprocessable
pxd-20240331_lab.xml Edgar Link unprocessable
pxd-20240331_pre.xml Edgar Link unprocessable
pxd-20240331_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pxd-20240331_cal.xml Edgar Link unprocessable